BIOMAT Database Logo BIOMAT Database Logo

Prolonged survival of hamster-to-rat pancreas xenografts by FK 506 and splenectomy. 1995

H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Second Department of Surgery, Hiroshima University School of Medicine, Japan.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000910 Antibodies, Heterophile Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification. Antibodies, Heterogenetic,Antibodies, Heterotypic,Antibodies, Xenogeneic,H-D Antibodies,Hanganutziu-Deicher Antibodies,Heteroantibodies,Heterologous Antibodies,Heterophile Antibodies,P-B Antibodies,Paul-Bunnell Antibodies,Xenoantibodies,Antibodies, Heterologous,Antibodies, Heterophil,Antibodies, Xenogenic,Forssman Antibody,Heterogenetic Antibodies,Antibody, Forssman,Heterophil Antibodies,Heterotypic Antibodies,Xenogeneic Antibodies,Xenogenic Antibodies

Related Publications

H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Hamster-to-rat xenotransplantation of whole pancreas by FK 506 combined with splenectomy.
April 1994, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.
December 1991, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Long-term survival of heart and liver xenografts with splenectomy and FK 506.
February 1993, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration.
December 1987, Transplantation,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
June 1994, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Prolonged cardiac allograft survival in sensitized rats by low-dose FK 506 in combination with splenectomy.
December 1991, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Prolonged survival of hamster-to-rat pulmonary xenografts by tacrolimus (FK506) and cyclophosphamide.
July 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Combination therapy with FK 506 and splenectomy may induce tolerance in cardiac xenografts.
June 1994, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Effect of FK 506 and splenectomy on orthotopic small bowel xenotransplantation in the hamster-to-rat animal models.
November 1998, Transplantation proceedings,
H Sakimoto, and Y Fukuda, and K Sumimoto, and T Urushihara, and M Ikeda, and K Yamanaka, and K Okugawa, and M Nishihara, and H Ito, and K Dohi
Prolonged survival of hepatic xenografts in the hamster to rat combination: efficacy of cyclosporine in combination with splenectomy.
February 1988, Transplantation proceedings,
Copied contents to your clipboard!